Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: AVID100 in Advanced Epithelial Carcinomas [Phase 1, Phase 2]
A phase 1/2 trial of AVID100 for advanced epithelial carcinomas was terminated; results were posted in June 2025.
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: A Study of EGF816 and Gefitinib in TKI-naïve EGFR-mutant Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 study of EGF816 (osimertinib) in combination with Gefitinib in TKI-naïve EGFR-mutant non-small cell lung cancer was terminated and…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: PD-1 Combined With Bevacizumab and PCSK-9 Inhibitor in Patients With Advanced NSCLC Who Have Progressed After Anti- PD- 1/L1 Therapy [Phase 2]
Phase 2 clinical trial evaluating a combination of a PD-1 inhibitor, Bevacizumab, and a PCSK-9 inhibitor in advanced non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Postoperative EGFR-TKI Therapy forContralateral Pulmonary Nodules in Patients With EGFR-Mutant NSCLC（ARMOR2501） [Phase 2]
Phase 2 trial ARMOR2501 evaluating postoperative EGFR-TKI therapy for contralateral pulmonary nodules in patients with EGFR-mutant non-small…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: The Safety and Feasibility of Costal Bone Marrow Aspiration During Thoracic Surgery [NA]
A terminated clinical trial evaluated the safety and feasibility of costal bone marrow aspiration during thoracic surgery in patients with n…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery [Phase 3]
Phase 3 trial comparing hippocampus-sparing whole-brain radiotherapy to stereotactic radiosurgery for patients with brain metastases from va…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Phase 1/2 Study of BBT-176 in Advanced NSCLC With Progression After EGFR TKI Treatment [Phase 1, Phase 2]
Phase 1/2 study of BBT-176 in advanced non-small cell lung cancer after progression on EGFR inhibitors has been terminated; results were pos…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Comparison of SPECT/CT Perfusion and Volumetric CT Volume
A clinical trial conducted in France comparing SPECT/CT perfusion with volumetric CT volume in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Factors Determine the Feasibility and Surgical Margin Quality of Sublobar Resection for Non-small Cell Lung Cancer?
A completed clinical trial evaluating the feasibility and surgical margin quality of sublobar resection for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 2 [Phase 2]
A Phase 2 sub-study of a platform trial comparing novel regimens against standard of care in non-small cell lung cancer was terminated, with…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies [Phase 1]
A Phase Ib safety study of Selinexor (KPT-330) in combination with standard chemotherapy or immunotherapy agents for patients with advanced …
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD
The study evaluating non-small cell lung cancer patients in the US initiating an approved therapy with risk of pneumonitis/ILD has been term…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study results show activity and safety of pralsetinib in RET-altered cancers, including non-small cell lung cancer and thyroid can…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Real World Utilization and Outcomes With Dacomitinib First Line Treatment for EGFR Mutation-positive Advanced Non Small Cell Lung Cancer Among Asian Patients - A Multi Center Chart Review
This update reports real-world utilization and outcomes of first-line dacomitinib for EGFR-mutant advanced non-small cell lung cancer among …
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies [Phase 2]
A Phase 2 trial evaluating platinum-pemetrexed-atezolizumab with or without bevacizumab for stage IIIB/IV non-squamous non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Neoadjuvant Durvalumab and Chemotherapy Followed by Surgery/CRT and Durvalumab in Borderline Resectable Stage III NSCLC [Phase 2]
Phase 2 neoadjuvant trial of durvalumab with chemotherapy followed by surgery or chemoradiation and continued durvalumab in borderline resec…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Pembrolizumab Plus Chemotherapy in NSCLC With Targetable Genetic Alterations After Progression on Targeted Agents [Phase 2]
Phase 2 trial results for pembrolizumab plus chemotherapy in non-small cell lung cancer with targetable genetic alterations after progressio…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC [Phase 1, Phase 2]
Phase 1/2 study evaluating the safety, immunogenicity, and preliminary clinical activity of the PDC*lung01 Cancer Vaccine in non-small cell …
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy [Phase 1, Phase 2]
This update reports results from a Phase 1/2 study of NGM120 in combination therapy for patients with advanced solid tumors, including pancr…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) - DISCOVER [Phase 1]
The DISCOVER Phase 1 trial evaluating RTA 408 in advanced solid tumors, including metastatic non-small cell lung cancer and relapsed/refract…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Chemoradiation Followed by Durvalumab in Poor Risk and/or Elderly Patients With Stage III NSCLC [Phase 2]
A Phase 2 trial evaluating chemoradiation followed by durvalumab for poor-risk and/or elderly patients with stage III non-small-cell lung ca…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study of IMM-6-415 in Ras/RAF-mutant solid tumors, including pancreatic ade…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Trial of NanoPac Intratumoral Injection in Lung Cancer [Phase 2]
A Phase 2 trial of NanoPac intratumoral injection in lung cancer has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial comparing chemotherapy/radiotherapy versus concomitant chemotherapy followed by radiotherapy in stage IIIB non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update reports termination of the NM21-1480 study in adults with advanced solid tumors, including non-small cell lung cance…